Back

Improvement in atrial functional and ventricular functional tricuspid regurgitation following catheter ablation or cardioversion of atrial fibrillation

7 April 2024 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: heart failure Rate Control EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Busra Kuru Gorgulu

Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul (Turkiye)

7 More presentations in this session

Presentation thumbnail
Single center experience of efficacy and safety of atrioventricular node ablation after left bundle branch area pacing for the management of atrial fibrillation
Doctor M. Jacobs (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Stroke after implantable cardioverter-defibrillator shocks in patients with heart failure
Mr M. Dyrbus (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Newly diagnosed heart failure in patients with atrial fibrillation referred for catheter ablation - identifying patients with arrhythmia-induced cardiomyopathy
Doctor J. Riess (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Definition and management of arrhythmia-induced cardiomyopathy: findings from the EHRA SIC survey
Associate Professor P. Badertscher (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation
Mrs R. Arnet (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: heart failure

The Event

Event poster

EHRA 2024

7 April 2024 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Catheter ablation for atrial fibrillation in patients with tricuspid regurgitation
thumbnail
Congress Presentation
Impact of atrial fibrillation on progression of tricuspid regurgitation in patients undergoing transcatheter aortic valve replacement
thumbnail
Congress Presentation
Is catheter ablation in atrial fibrillation patients with functional tricuspid regurgitation as effective as in patients with functional mitral regurgitation?